DR info

Clinical trials : 27 / Drugs : 30 - (DrugBank : 15) / Drug target genes : 14 - Drug target pathways : 153

Huge arteriovenous malformation with cervicofacial or limb lesion and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
280	Huge arteriovenous malformation with cervicofacial or limb lesion
46	Malignant rheumatoid arthritis
96	Crohn disease
2	Amyotrophic lateral sclerosis
13	Multiple sclerosis/Neuromyelitis optica
34	Neurofibromatosis
288	Autoimmune acquired coagulation factor deficiency
6	Parkinson disease
118	Myelomeningocele
70	Spinal stenosis
169	Menkes disease
170	Occipital horn syndrome
206	Fragile X syndrome
17	Multiple system atrophy
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
22	Moyamoya disease
11	Myasthenia gravis
323	Aromatic L-amino acid decarboxylase deficiency
279	Huge venous malformation with cervical, oral and pharyngeal diffuse lesion
113	Muscular dystrophy
226	Interstitial cystitis with Hunners ulcer
5	Progressive supranuclear palsy
8	Huntington disease
67	Polycystic kidney disease
58	Hypertrophic cardiomyopathy
107	Juvenile idiopathic arthritis
65	Primary immunodeficiency
51	Scleroderma
215	Tetralogy of Fallot
212	Tricuspid atresia
57	Idiopathic dilated cardiomyopathy
310	Congenital anomalies syndrome
127	Frontotemporal lobar degeneration
271	Ankylosing spondylitis
78	Hypopituitarism
90	Retinitis pigmentosa
28	Systemic amyloidosis
15	Inclusion body myositis
84	Sarcoidosis
97	Ulcerative colitis
4	Primary lateral sclerosis
254	Porphyria
281	Klippel-Trenaunay-Weber syndrome
317	Trifunctional protein deficiency
137	Focal cortical dysplasia
192	Cockayne syndrome
277	Lymphangiomatosis